MYC and diffuse large B-cell lymphoma: Carey et al. [12] performed targeted GEP and identified a molecular classifier of MYC activity including 80 genes that stratified DLBCL patients into high- (MYC score > 0.5) and low-risk (MYC score < 0.5) groups.